• Served as a unit level leader for patient safety and quality improvement work and supported institutional initiatives and regulatory requirements that impact patient outcomes.• FY18: Sustained statistically significant change in HAVI and CLABSI which signaled centerline shifts down. Increased average days between all harm from 18 to 37 days, decreasing overall Harm Index by 57%. Established longest days since last harm for PIVIE (372 days), HAPI (860 days), VTE (585+ days), CLABSI (305+ days)• FY17: Reduced rate of PIV Infiltrates with Harm by 39%, established special cause variation with centerline shift for PIV Infiltrates with Harm. Decreased rate of HAPI with harm by 100%, established special cause variation with centerline shift for reportable HAPI. Decreased rate of Falls with Injury by 47% to below the hospital-wide target of 0.29 Falls with Injury per 1000 patient days. Served as hospital-wide Venous Thromboembolism (VTE) nurse co-leader and implemented VTE prevention clinical pathway, while supporting unit-based representatives in improving adherence to standard prevention practices. • FY16: Collaborated with multidisciplinary team to facilitate 40% reduction in PIV infiltrates with harm, 56% reduction in central line-associated bloodstream infections despite 13% increase in line days, 36% reduction in nosocomial viral infections despite 5% increase in patient days.

Mentor Capstone I & II students pursuing graduate certificate or Masters in Healthcare Quality & SafetyGuest lecturer for MHQS6500 Systems Thinking and Patient Safety, Using Quality Improvement to Achieve Health Equity